Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Medtronic Haft collagen-impregnated aortic valved conduit is available worldwide at a list price of $4,995. The product of a licensing agreement between Medtronic and Meadox Medicals, the device combines a Medtronic Hall mechanical heart valve with a Meadox 13 cm-long Hemashield tapered, woven, polyester conduit and "is used by surgeons to replace a diseased or damaged aortic valve and the ascending aorta," Medtronic says. The device offers a larger diameter than other conduits on the market; it is being sold in seven sizes, ranging from 21 mm to 33 mm in diameter. A premarket approval application supplement for the device was approved by FDA May 12, approximately eight months after the application was filed. St. Jude began sales of its collagen- impregnated aortic valved graft in March. The device combines a St. Jude mechanical heart valve with Meadox' Hemashield

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel